ATX 61.3% 10.0¢ amplia therapeutics limited

more importantly at the 4 month point 5 out of 6 showed...

  1. 2,679 Posts.
    lightbulb Created with Sketch. 179
    more importantly at the 4 month point 5 out of 6 showed progression free survival ? is that how you read it ?
    in other words
    50% of patients(3/6) had 30% reduction of tumour size that sustained for 2 months at the end of 4 months

    another 30% or 2/6 Patients had a stable disease at the end of 4 months

    so almost 80%+ had progression free disease ?
    Last edited by Meledath: Yesterday, 18:44
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
0.038(61.3%)
Mkt cap ! $27.42M
Open High Low Value Volume
7.0¢ 10.0¢ 7.0¢ $328.8K 3.969M

Buyers (Bids)

No. Vol. Price($)
1 13700 9.9¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 24649 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.